Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin. - Wikidata - wikimedia - TriplyDB

Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.

Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.

http://www.wikidata.org/entity/Q44386599

about

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals Integrated therapy for HIV and tuberculosis Diagnosis & treatment of tuberculosis in HIV co-infected patients.Outcomes for efavirenz versus nevirapine-containing regimens for treatment of HIV-1 infection: a systematic review and meta-analysis HIV and Tuberculosis: a Deadly Human Syndemic Durability of stavudine, lamivudine and nevirapine among advanced HIV-1 infected patients with/without prior co-administration of rifampicin: a 144-week prospective study.Effect of pulmonary tuberculosis on mortality in patients receiving HAART.AtriplaR/anti-TB combination in TB/HIV patients. Drug in focus Tuberculosis as part of the natural history of HIV infection in developing countries Initiating antiretrovirals during tuberculosis treatment: a drug safety review.CYP2B6 G516T polymorphism but not rifampin coadministration influences steady-state pharmacokinetics of efavirenz in human immunodeficiency virus-infected patients in South India Nevirapine versus efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and tuberculosis infections in India: a pilot study.HIV-related liver disease: ARV drugs, coinfection, and other risk factors.Body weight cutoff for daily dosage of efavirenz and 60-week efficacy of efavirenz-based regimen in human immunodeficiency virus and tuberculosis coinfected patients receiving rifampin.Management of individuals requiring antiretroviral therapy and TB treatment.Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients Tuberculosis and HIV co-infection: screening and treatment strategies.Early changes in hepatic function among HIV-tuberculosis patients treated with nevirapine or efavirenz along with rifampin-based anti-tuberculosis therapy.Efficacy and safety of once-daily nevirapine- or efavirenz-based antiretroviral therapy in HIV-associated tuberculosis: a randomized clinical trial.Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.

P2860

Q24235724-9ECD57CD-4096-42BE-97A0-351F8B5EA4D6 Q26749428-0E641125-EEF3-48DA-8547-B23A9B94EAC5 Q26991633-4135D8CC-5B8F-4557-A5D9-C298FC893F88 Q27021762-094F1408-CC8D-45F9-928E-6CDD8B2C5968 Q30052157-6A9BD145-8C4B-49A8-BA97-09B63F58D482 Q33375532-C76E056B-3952-4E1E-A2B4-585B41A2D5CB Q33764880-0D0E1AA6-3DAB-41B5-B37B-C019B3657B88 Q34083071-9E77D2DD-3DFE-487C-942C-6CF9114135B5 Q34547644-1971BC83-3C73-4F83-BDB0-451CA0FD0386 Q35043048-D0B04267-1122-4E24-97B5-3447222BE43F Q37115738-03F76434-F063-4CA6-B5B7-6F39D3E927E4 Q37369594-45705EB4-6BCA-40DA-9589-F357BFCE43E3 Q37391122-22B94B23-60C3-49DB-BCF5-A3DF5068113E Q37392789-40A23C41-4C1A-47C5-A5AD-977AEEDB1714 Q37666456-39D126E1-EEB6-4F96-BD4E-C43415C89177 Q37690861-6074E13A-C070-469D-8B5A-2739402ECC9F Q37895251-6D95E2D1-EFDC-4AE2-8826-A0987B1287DC Q41392118-21DB2319-DE6A-4B08-AEDD-EF88F8CCA71C Q42615157-76220038-F365-4D82-8AB1-6F8F7A8A71A6 Q47102399-2AAC3A30-6C20-4791-86B2-DEEF33315C73

P2860

Standard-dose efavirenz vs. standard-dose nevirapine in antiretroviral regimens among HIV-1 and tuberculosis co-infected patients who received rifampicin.

http://www.wikidata.org/entity/Q44386599

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh-hant

name

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@en

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@nl

type

label

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@en

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@nl

prefLabel

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@en

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@nl

P1433

Q44386599-6CEF293A-98B7-4FC5-9169-089D4DF21EA0

P1476

Q44386599-8FCD3D7D-2FA2-45B0-B1F6-9470398E227D

P2093

Q44386599-259FA7EF-0E4C-4134-812C-0F02E8B50299

Q44386599-773E5FEE-5C85-4A22-A6E3-CCA4B107442C

Q44386599-92C86460-8CF1-4587-8021-EC3C1A3F1A56

Q44386599-A507B6A5-8BC7-4ABA-87D2-51FD6F095E84

Q44386599-DBD69D57-2A9D-411E-A9D5-F9079BB3D4C0

P2860

Q44386599-096600C4-25BE-44CE-90E8-07F0C26E709E

Q44386599-158498A0-BA43-46B8-A59B-1A9ADEE9C1E5

Q44386599-227335AC-D948-46BF-878D-BABF214BE510

Q44386599-28EEC958-BD6A-4FC8-9338-49A73205765D

Q44386599-49A235EF-A9C2-4F8C-905C-C427BC9DD0FA

Q44386599-5BB6EB7A-8FC0-4840-BEEA-0152948430E2

Q44386599-5D6FE8E3-BB40-42EC-ABC5-3542789F33F5

Q44386599-60A8B5BE-FFA3-4AFB-ADDA-203C3A777E95

Q44386599-66E4B222-98AB-41B9-BE11-E4A72797F8A1

Q44386599-75D5C2C7-FEA4-430E-BACC-78CF1920EA2B

P304

Q44386599-15F81120-788D-4B85-AB15-1CF6E97B3048

P31

Q44386599-3CB8FAAB-BCF4-400B-99A9-B34B4BE84CDA

P356

Q44386599-657B983B-D47E-492C-A2F8-EFEAE33865C6

P433

Q44386599-92246929-1F1D-4D72-B68D-E8029A711C44

P478

Q44386599-66418362-0E44-49EF-95CE-929CCEA8BD57

P577

Q44386599-B8D79DC3-1FFA-411A-BA45-33E42820EDA3

P5875

Q44386599-1BFDD3CA-366E-4A2D-872B-CEA8A5E8D53A

P698

Q44386599-6B99EE39-D672-406C-9125-CD0AB7B309C1

P921

Q44386599-FFCC1CB1-4E9D-4F5D-9F40-29F85DE99ACC

P356

J.1468-1293.2008.00563.X

P1433

P1476

Standard-dose efavirenz vs. st ...... ients who received rifampicin.

@en

P2093

A Lueangniyomkul

http://www.w3.org/2001/XMLSchema#string

S Chimsuntorn

http://www.w3.org/2001/XMLSchema#string

S Sungkanuparph

http://www.w3.org/2001/XMLSchema#string

W Mankatitham

http://www.w3.org/2001/XMLSchema#string

W Manosuthi

http://www.w3.org/2001/XMLSchema#string

P2860

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients.

Treatment Options for HIV-Associated Tuberculosis.

Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.

A review of efficacy studies of 6-month short-course therapy for tuberculosis among patients infected with human immunodeficiency virus: differences in study outcomes.

Rifampin and rifabutin drug interactions: an update.

Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study

Tuberculosis and HIV infection: the global setting.

Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome.

Standardized tuberculosis treatment outcome monitoring in Europe. Recommendations of a Working Group of the World Health Organization (WHO) and the European Region of the International Union Against Tuberculosis and Lung Disease (IUATLD) for uniform

P304

294-299

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-1293.2008.00563.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5452786

http://www.w3.org/2001/XMLSchema#string

P698

18400076

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde